Patients with diabetic macular edema previously treated with a ranibizumab biosimilar in India experience comparable safety ...

Continuous administration of ranibizumab with a port delivery system provides an alternative to frequent intravitreal ...

Macular degeneration, particularly age-related macular degeneration (AMD), is a leading cause of vision loss worldwide. This condition affects the central part of the retina, known as the macula, ...

MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) announced progress in its Phase 1 clinical trial for OCU200, a novel biologic ...

Obstructive sleep apnea is associated with higher rates of age-related macular degeneration development and progression.

Additionally, the prognosis of macular edema may help clinicians evaluate renal function, investigators reported ...

Types of wet AMD treatments. The main treatment involves eye injections of anti-VEGF drugs to stop problematic blood vessel growth. Options include aflibercept, bevacizumab, brolucizumab ...

In the randomized, sham-controlled ARTEMIS study, patients will receive either a dose of ixo-vec or a standard care regimen of anti-VEGF Eylea.

CLS-AX Phase 3 Program Designed to Maximize Commercial Potential in Wet AMD -- Flexible Dosing and Extended Duration would be Important ...

Ixo-vec is a potential best-in-class one-time gene therapy designed to deliver long-term efficacy, reduce the burden of frequent anti-VEGF and ...